So far, indeed, the role of TGFbeta in the liver had been widely explored in pathological conditions (cancer, fibrosis, compensatory regeneration and control of liver mass under mitogenic stimulus) [46–49], while data on its contribution to physiological processes are quite poor. This evidence concerns the gene TGFB1 and cancer.